The Impact of MassPAT on Opioid Prescribing Patterns for Otolaryngology Surgeries

• Published in: Otolaryngology-head and neck surgery Vol. 164; no. 4; p. 781
• Main Authors: Rubin, Samuel, Wulu, Jacqueline A, Edwards, Heather A, Dolan, Robert W, Brams, David M, Yarlagadda, Bharat B
• Format: Journal Article
• Language: English
• Published: England 01.04.2021
• Subjects: tonsillectomy; thyroid surgery; general otolaryngology; parotidectomy; opioids
• ISSN: 1097-6817
• DOI: 10.1177/0194599820987454

Determine whether opioid prescriber patterns have changed for tonsillectomy, parotidectomy, and thyroidectomy after implementation of the Massachusetts Prescription Awareness Tool (MassPAT). Retrospective cohort study. Single-center tertiary care hospital. Patients were included if they received tonsillectomy, parotidectomy, or thyroid surgery at Lahey Hospital and Medical Center (Burlington, Massachusetts) between October 1, 2015, and October 1, 2019. Prescribing patterns were compared prior to implementation of MassPAT, October 1, 2015, to October 14, 2016, to postimplementation of MassPAT, October 15, 2016, to October 1, 2019. Quantity of opioids prescribed was described using total morphine milligram equivalents (MME). Data were analyzed using univariate analysis, multivariate analysis, and trend line using line of best fit. A total of 737 subjects were included in the study. There was a downward trend in the quantity of opioids prescribed for all 3 surgeries during the study period. There was a significant difference in the quantity of opioids prescribed pre- and postimplementation of MassPAT for tonsillectomy (647.70 ± 218.50 MME vs 474.60 ± 185.90 MME, < .001), parotidectomy (241.20 ± 57.66 MME vs 156.70 ± 72.99 MME, < .001), and thyroidectomy (171.20 ± 93.77 MME vs 108.50 ± 63.84 MME, < .001). There was also a decrease in the number of patients who did not receive opioids for thyroidectomy pre- and post-MassPAT (7.56% vs 24.14%). We have demonstrated that there is an association with state drug monitoring programs and decrease in the amount of opioids prescribed for acute postoperative pain control for common otolaryngology surgeries.